ConductScience.org, home

Gene · 338413

NIH grants2,325

NIH grants whose papers are about the gene, through NIH's grant-paper links.

121 to 140 of 2,325

Download this page as JSON
GrantTitleTAS2R63P papersNewest fiscal year
R35NS105109Molecular Mechanisms of Drug Resistance in Primary Brain Tumors22025
R37AR040072Immune Responses in Lupus22025
R50CA211447Developing chemical probes for oncogenic signaling pathways22025
T32AI007019Interdisciplinary Immunology Training Program22025
T32CA009207Investigational Cancer Therapeutics Training Program (ICTTP)22025
T32CA009302Leveraging innovative technologies in basic and clinical cancer research22025
T32CA009592Microenvironmental Influences in Cancer22025
T32CA009599Training of Academic Surgical Oncologists22025
T32CA082088T32 Urologic Oncology Research Training Grant22025
U01AG022303Interventions Testing Program at UM22025
U10CA180821Alliance for Clinical Trials in Oncology Operations Center - GY11 Funded Extension22025
U10CA180882Alliance Statistics and Data Management Center22025
U19AG056278Genetic variant-based drug discovery targeting conserved pathways of aging22025
U54GM104940Louisiana Clinical and Translational Science Center22025
UL1TR001881UCLA Clinical and Translational Science Institute22025
UM1AI164562ERASE HIV: Enterprise for Research and Advancements to Stop and Eradicate HIV22025
UM1CA186691The Johns Hopkins Translational Science Team and Consortium for ETCTN Studies22025
ZIAAI001122Studies of Inherited Causes of Fungal Susceptability22025
ZIACL010304Mutation Analysis Of Selected Lymphoid Immune Disorders22025
ZIADK075140Cross-talk between oncogene-driven signaling pathways and thyroid cancer metabolism22025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/338413/grants?page=7